Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

WP2 - Biomarker discovery in observational prospective studies

WP leaders
 

Charlotte Ling and Hindrik Mulder

Objectives

  • To identify and validate new biomarkers for early onset of disease
  • To identify and validate new biomarkers from and applicable to, broad populations in order to predict disease progression (including complications), as well as to explore whether these biomarkers are enriched in some to the new clusters obtained by using a more fine-tuned diabetes classification
  • To identify and validate new biomarkers of efficacy response, including dynamic biomarkers that change with interventions (i.e. experimental therapeutic, Standard of Care, life style interventions)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Press releases

Selected publications